BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11564802)

  • 1. Conventional and surrogate light chains differentially regulate Ig mu and Dmu heavy chain maturation and surface expression.
    Fang T; Smith BP; Roman CA
    J Immunol; 2001 Oct; 167(7):3846-57. PubMed ID: 11564802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
    Shaffer AL; Schlissel MS
    J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unique region of surrogate light chain component lambda5 is a heavy chain-specific regulator of precursor B cell receptor signaling.
    Guloglu FB; Bajor E; Smith BP; Roman CA
    J Immunol; 2005 Jul; 175(1):358-66. PubMed ID: 15972669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of murine precursor B cell receptor with stroma cells is controlled by the unique tail of lambda 5 and stroma cell-associated heparan sulfate.
    Bradl H; Wittmann J; Milius D; Vettermann C; Jäck HM
    J Immunol; 2003 Sep; 171(5):2338-48. PubMed ID: 12928380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple levels of selection responsive to immunoglobulin light chain and heavy chain structures impede the development of Dmu-expressing B cells.
    Guloglu FB; Smith BP; Roman CA
    J Immunol; 2008 Sep; 181(6):4098-106. PubMed ID: 18768866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The VpreB protein of the surrogate light-chain can pair with some mu heavy-chains in the absence of the lambda 5 protein.
    Seidl T; Rolink A; Melchers F
    Eur J Immunol; 2001 Jul; 31(7):1999-2006. PubMed ID: 11449352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: signaling and cell surface expression of a mu H chain in the absence of lambda 5: a paradigm revisited.
    Schuh W; Meister S; Roth E; Jäck HM
    J Immunol; 2003 Oct; 171(7):3343-7. PubMed ID: 14500626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components.
    Galler GR; Mundt C; Parker M; Pelanda R; Mårtensson IL; Winkler TH
    J Exp Med; 2004 Jun; 199(11):1523-32. PubMed ID: 15173209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A complex of glycoproteins is associated with VpreB/lambda 5 surrogate light chain on the surface of mu heavy chain-negative early precursor B cell lines.
    Karasuyama H; Rolink A; Melchers F
    J Exp Med; 1993 Aug; 178(2):469-78. PubMed ID: 8340754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The unique and immunoglobulin-like regions of surrogate light chain component lambda5 differentially interrogate immunoglobulin heavy-chain structure.
    Smith BP; Roman CA
    Mol Immunol; 2010 Mar; 47(6):1195-206. PubMed ID: 20116104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-B cell receptor-mediated selection of pre-B cells synthesizing functional mu heavy chains.
    Kline GH; Hartwell L; Beck-Engeser GB; Keyna U; Zaharevitz S; Klinman NR; Jäck HM
    J Immunol; 1998 Aug; 161(4):1608-18. PubMed ID: 9712022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated immunoglobulin Dmu causes incomplete developmental progression of RAG-deficient pro-B cells.
    Malynn BA; Shaw AC; Young F; Stewart V; Alt FW
    Mol Immunol; 2002 Jan; 38(7):547-56. PubMed ID: 11750656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-B-cell development in the absence of lambda 5 in transgenic mice expressing a heavy-chain disease protein.
    Corcos D; Dunda O; Butor C; Cesbron JY; Lorès P; Bucchini D; Jami J
    Curr Biol; 1995 Oct; 5(10):1140-8. PubMed ID: 8548286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Ig mu heavy chains by complementarity-determining region 3 length and amino acid composition.
    Martin DA; Bradl H; Collins TJ; Roth E; Jäck HM; Wu GE
    J Immunol; 2003 Nov; 171(9):4663-71. PubMed ID: 14568941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
    van Loo PF; Dingjan GM; Maas A; Hendriks RW
    Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of soluble pre-B cell receptors by pre-B cells.
    Bornemann KD; Brewer JW; Perez E; Doerre S; Sita R; Corley RB
    J Immunol; 1997 Mar; 158(6):2551-7. PubMed ID: 9058786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial block in B lymphocyte development at the transition into the pre-B cell receptor stage in Vpre-B1-deficient mice.
    Mårtensson A; Argon Y; Melchers F; Dul JL; Mårtensson IL
    Int Immunol; 1999 Mar; 11(3):453-60. PubMed ID: 10221657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 14.1 surrogate light chain promoter has lineage- and stage-restricted activity.
    Donohoe ME; Blomberg BB
    J Immunol; 1997 Feb; 158(4):1681-91. PubMed ID: 9029104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanisms control the folding and assembly of lambda5/14.1 and VpreB to produce an intact surrogate light chain.
    Minegishi Y; Hendershot LM; Conley ME
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3041-6. PubMed ID: 10077633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin mu heavy chains do not mediate tyrosine phosphorylation of Ig alpha from the ER-cis-Golgi.
    Mielenz D; Ruschel A; Vettermann C; Jäck HM
    J Immunol; 2003 Sep; 171(6):3091-101. PubMed ID: 12960335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.